Telithromycin

Results: 51



#Item
21Microsoft PowerPoint - 14_Main_Sanders-MG_vers1-5.ppt

Microsoft PowerPoint - 14_Main_Sanders-MG_vers1-5.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-01-16 14:32:19
22Doxycycline Vision Disorders

Doxycycline Vision Disorders

Add to Reading List

Source URL: www.fda.gov

Language: English
23Microsoft PowerPoint - 01_Main-Introduction_ver2-2.ppt

Microsoft PowerPoint - 01_Main-Introduction_ver2-2.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-01-16 14:32:12
24Microsoft PowerPoint - 13_Kardon_VisualAE_ver1-3.ppt

Microsoft PowerPoint - 13_Kardon_VisualAE_ver1-3.ppt

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2007-01-16 14:32:19
25Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. §355 (n)(4) Carl Norden, M.D. Committees:  Anti-Infective Drugs Advisory Committee an

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. §355 (n)(4) Carl Norden, M.D. Committees: Anti-Infective Drugs Advisory Committee an

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-29 08:57:22
26Rx DRUG INTERACTIONS  Absence of Proof Is Not Proof of Absence John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD Drs. Horn and Hansten are both professors of pharmacy at the University of

Rx DRUG INTERACTIONS Absence of Proof Is Not Proof of Absence John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD Drs. Horn and Hansten are both professors of pharmacy at the University of

Add to Reading List

Source URL: www.hanstenandhorn.com

Language: English - Date: 2010-05-03 01:00:59
27Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U. S.C. $208 (b)(3) Lou Morris, Ph.D. Committees:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U. S.C. $208 (b)(3) Lou Morris, Ph.D. Committees:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-29 08:57:21
28Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Jennifer Dunbar, M. D. Committees:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Jennifer Dunbar, M. D. Committees:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-29 08:57:20
29DEPARTMENT OF HEALTH & HUMAN SERVICES  Publ~cHealth Service Food and Drug Administration Rockville MD 20857

DEPARTMENT OF HEALTH & HUMAN SERVICES Publ~cHealth Service Food and Drug Administration Rockville MD 20857

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-29 08:57:19
30Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U.S.C. $208 (b)(3) John Edwards, Jr., M.D. Committees:

Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 18 U.S.C. $208 (b)(3) John Edwards, Jr., M.D. Committees:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2006-11-29 08:57:20